Prioritization of genetic variants predisposing to coronary heart disease in the Bulgarian population using centenarian exomes

References

• Sanchis-Gomar F, Perez-Quilis C, Leischik R, et al. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256.
   PubMed Web of Science ®Google Scholar
• Ferreira-González I. The epidemiology of coronary heart disease. Rev Esp Cardiol. 2014;67(2):139–144.
   PubMed Web of Science ®Google Scholar
• Kzhyshkowska J, Neyen C, Gordon S. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 2012;217(5):492–502.
   PubMed Web of Science ®Google Scholar
• Linton MF, Tao H, Linton EF, et al. SR-BI: a multifunctional receptor in cholesterol homeostasis and atherosclerosis. Trends Endocrinol Metab. 2017;28(6):461–472.
   PubMed Web of Science ®Google Scholar
• Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med. 2014;46:e99.
   PubMed Web of Science ®Google Scholar
• Pothineni NVK, Karathanasis SK, Ding Z, et al. LOX-1 in atherosclerosis and myocardial ischemia: biology, genetics, and modulation. J Am Coll Cardiol. 2017;69(22):2759–2768.
   PubMed Web of Science ®Google Scholar
• Fatkhullina AR, Peshkova IO, Koltsova EK. The role of cytokines in the development of atherosclerosis. Biochemistry Moscow. 2016;81(11):1358–1370.
   Google Scholar
• Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014;22(3):147–151.
   PubMed Web of Science ®Google Scholar
• Hu W, Huang Y. Targeting the platelet-derived growth factor signalling in cardiovascular disease. Clin Exp Pharmacol Physiol. 2015;42(12):1221–1224.
   PubMed Web of Science ®Google Scholar
• Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol. 2017;70(18):2278–2289.
   PubMed Web of Science ®Google Scholar
• Oikonomou E, Economou EK, Tousoulis D, et al. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J. 2016;37(22):1723–1732.
   PubMed Web of Science ®Google Scholar
• van der Vorst EPC, Döring Y, Weber C. Chemokines and their receptors in atherosclerosis. J Mol Med. 2015;93(9):963–971.
   PubMed Web of Science ®Google Scholar
• Xie W, Li L, Zheng X-L, et al. The role of Krüppel-like factor 14 in the pathogenesis of atherosclerosis. Atherosclerosis 2017;263:352–360.
   PubMed Web of Science ®Google Scholar
• Zeng L, Dang TA, Schunkert H. Genetics links between transforming growth factor β pathway and coronary disease. Atherosclerosis 2016;253:237–246.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. Endothelial PECAM-1 and its function in vascular physiology and atherogenic pathology. Exp Mol Pathol. 2016;100(3):409–415.
   PubMed Web of Science ®Google Scholar
• Finney AC, Stokes KY, Pattillo CB, et al. Integrin signaling in atherosclerosis. Cell Mol Life Sci. 2017;74(12):2263–2282.
   PubMed Web of Science ®Google Scholar
• McEver RP. Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res. 2015;107(3):331–339.
   PubMed Web of Science ®Google Scholar
• Schmidt EP, Kuebler WM, Lee WL, et al. Adhesion molecules: master controllers of the circulatory system. Compr Physiol. 2016;6(2):945–973.
   PubMed Web of Science ®Google Scholar
• Brown BA, Williams H, George SJ. Evidence for the involvement of matrix-degrading metalloproteinases (MMPs) in atherosclerosis. Prog Mol Biol Transl Sci. 2017;147:197–237.
   PubMed Web of Science ®Google Scholar
• Ruddy JM, Ikonomidis JS, Jones JA. Multidimensional contribution of matrix metalloproteinases to atherosclerotic plaque vulnerability: multiple mechanisms of inhibition to promote stability. J Vasc Res. 2016;53(1-2):1–16.
   PubMed Web of Science ®Google Scholar
• Vacek TP, Rehman S, Neamtu D, et al. Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms. Vasc Health Risk Manag. 2015;11:173–183.
   PubMed Web of Science ®Google Scholar
• Dimitris T, Anna-Maria K, Costas Tentolouris Nikolaos P, et al. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10(1):4–18.
   PubMed Web of Science ®Google Scholar
• Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713–735.
   PubMed Web of Science ®Google Scholar
• Li H, Horke S, Förstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis 2014;237(1):208–219.
   PubMed Web of Science ®Google Scholar
• El Assar M, Angulo J, Rodríguez-Mañas L. Oxidative stress and vascular inflammation in aging. Free Radic Biol Med. 2013;65:380–401.
   PubMed Web of Science ®Google Scholar
• Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal. 2011;15(6):1583–1606.
   PubMed Web of Science ®Google Scholar
• Kattoor AJ, Pothineni NVK, Palagiri D, et al. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42.
   PubMed Web of Science ®Google Scholar
• Chinetti-Gbaguidi G, Staels B. PPARβ in macrophages and atherosclerosis. Biochimie 2017;136:59–64.
   PubMed Web of Science ®Google Scholar
• Jakobs P, Serbulea V, Leitinger N, et al. Nuclear factor (erythroid-derived 2)-like 2 and thioredoxin-1 in atherosclerosis and ischemia/reperfusion injury in the heart. Antioxid Redox Signal. 2017;26(12):630–644.
   PubMed Web of Science ®Google Scholar
• Yu X-H, Zheng X-L, Tang C-K. Chapter 7: Peroxisome proliferator-activated receptor α in lipid metabolism and atherosclerosis. In: Makowski GS, editor. Advances in clinical chemistry. Vol. 71. Amsterdam: Elsevier; 2015. p. 171–203.
   Google Scholar
• Yu X-H, Zheng X-L, Tang C-K. Chapter 1: Nuclear factor-κB activation as a pathological mechanism of lipid metabolism and atherosclerosis. In: Makowski GS, editor. Advances in clinical chemistry. Vol. 70: Amsterdam: Elsevier; 2015. p. 1–30.
   Google Scholar
• Kirov G, Zaharieva I, Georgieva L, et al. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry. 2009;14(8):796–803.
   PubMed Web of Science ®Google Scholar
• Popp B, Ekici AB, Thiel CT, et al. Exome pool-seq in neurodevelopmental disorders. Eur J Hum Genet. 2017;25(12):1364–1376.
   PubMed Web of Science ®Google Scholar
• Schlötterer C, Tobler R, Kofler R, et al. Sequencing pools of individuals — mining genome-wide polymorphism data without big funding. Nat Rev Genet. 2014;15(11):749–763.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10(10):1556–1566.
   PubMed Web of Science ®Google Scholar
• Zerbino DR, Achuthan P, Akanni W, et al. Ensembl 2018. Nucleic Acids Res. 2018;46(D1):D754–D761.
   PubMed Web of Science ®Google Scholar
• Piñero J, Bravo À, Queralt-Rosinach N, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45(D1):D833–D9.
   PubMed Web of Science ®Google Scholar
• Chen J, Bardes EE, Aronow BJ, et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37(Web Server issue):W305–W11.
   PubMed Web of Science ®Google Scholar
• Pita-Juárez Y, Altschuler G, Kariotis S, et al. The pathway coexpression network: revealing pathway relationships. PLoS Comput Biol. 2018;14(3):e1006042.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289–300.
   Web of Science ®Google Scholar
• Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Statist. 2001;29(4):1165–1188.
   Web of Science ®Google Scholar
• Frey UH, Moebus S, Mohlenkamp S, et al. GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study. Atherosclerosis 2014;237(2):437–442.
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Takamura T, Abe T, et al. Association of the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications, and diabetic therapies among Japanese. Metabolism 2007;56(1):44–48.
   PubMed Web of Science ®Google Scholar
• Niu C, Luo Z, Yu L, et al. Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis. Lipids Health Dis. 2017;16(1):166.
   PubMed Web of Science ®Google Scholar
• Karami F, Salahshourifar I, Houshmand M. The study of rs693 and rs515135 in APOB in people with familial hypercholestrolemia. Cell J. 2019;21(1):86–91.
   PubMed Web of Science ®Google Scholar
• Shan J-G, Xue S. MTHFR C677T polymorphism and coronary artery disease risk in the Chinese population: a meta-analysis based on 33 studies. Int J Clin Exp Med 2016;9(2):2822–2830.
   Web of Science ®Google Scholar
• Ericson U, Sonestedt E, Ivarsson MI, et al. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1101–1110.
   PubMed Web of Science ®Google Scholar
• Luo Z, Lu Z, Muhammad I, et al. Associations of the MTHFR rs1801133 polymorphism with coronary artery disease and lipid levels: a systematic review and updated meta-analysis. Lipids Health Dis. 2018;17(1):191.
   PubMed Web of Science ®Google Scholar
• Schuchardt JP, Köbe T, Witte V, et al. Genetic variants of the FADS gene cluster are associated with erythrocyte membrane LC PUFA levels in patients with mild cognitive impairment. J Nutr Health Aging. 2016;20(6):611–620.
   PubMed Web of Science ®Google Scholar
• Hallmann J, Kolossa S, Gedrich K, et al. Predicting fatty acid profiles in blood based on food intake and the FADS1 rs174546 SNP. Mol Nutr Food Res. 2015;59(12):2565–2573.
   PubMed Web of Science ®Google Scholar
• Bokor S, Dumont J, Spinneker A, et al. Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios. J Lipid Res. 2010;51(8):2325–2333.
   PubMed Web of Science ®Google Scholar
• Kächele M, Hennige AM, Machann J, et al. Variation in the phosphoinositide 3-kinase gamma gene affects plasma HDL-cholesterol without modification of metabolic or inflammatory markers. PLoS One. 2015;10(12):e0144494.
   PubMed Web of Science ®Google Scholar
• Hamidizadeh L, Haji Hosseini Baghdad Abadi R, Babaee Baigi MA, et al. Impact of KIF6 polymorphism rs20455 on coronary heart disease risk and effectiveness of statin therapy in 100 patients from Southern Iran. Arch Iran Med. 2015;18(10):683–687.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen Z, Song H. Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls. Lipids Health Dis. 2018;17(1):4.
   PubMed Web of Science ®Google Scholar
• Vishnuprabu D, Geetha S, Bhaskar L, et al. Genotyping and meta-analysis of KIF6 Trp719Arg polymorphism in South Indian Coronary Artery Disease patients: A case-control study. Meta Gene. 2015;5:129–134.
   PubMed Web of Science ®Google Scholar
• Vergeer M, Cohn DM, Boekholdt SM, et al. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. Atherosclerosis 2010;211(2):558–564.
   PubMed Web of Science ®Google Scholar
• Badellino KO, Wolfe ML, Reilly MP, et al. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med. 2005;3(2):e22.
   PubMed Web of Science ®Google Scholar
• Edmondson AC, Brown RJ, Kathiresan S, et al. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest. 2009;119(4):1042–1050.
   PubMed Web of Science ®Google Scholar
• Wang F, Ji Y, Chen X, et al. ABCA1 variants rs2230806 (R219K), rs4149313 (M8831I), and rs9282541 (R230C) are associated with susceptibility to coronary heart disease. J Clin Lab Anal. 2019;33(6):20.
   Web of Science ®Google Scholar
• Ma XY, Liu JP, Song ZY. Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: a meta-analysis. Atherosclerosis 2011;215(2):428–434.
   PubMed Web of Science ®Google Scholar
• Ghaznavi H, Aali E, Soltanpour MS. Association study of the ATP - binding cassette transporter A1 (ABCA1) Rs2230806 genetic variation with lipid profile and coronary artery disease risk in an Iranian population. Open Access Maced J Med Sci. 2018;6(2):274–279.
   PubMedGoogle Scholar
• Wu N, Zhang X, Jia P, et al. Lack of an association between the SDF-1 rs1801157 polymorphism and coronary heart disease: a meta-analysis. Sci Rep. 2015;5(1):11803.
   PubMed Web of Science ®Google Scholar